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Abstract DNA has been described as a structural
component of the extracellular matrix (ECM) in
bacterial biofilms. In Candida albicans, there is a
scarce knowledge concerning the contribution of
extracellular DNA (eDNA) to biofilm matrix and
overall structure. This work examined the presence
and quantified the amount of eDNA in C. albicans
biofilm ECM and the effect of DNase treatment and
the addition of exogenous DNA on C. albicans
biofilm development as indicators of a role for eDNA
in biofilm development. We were able to detect the
accumulation of eDNA in biofilm ECM extracted
from C. albicans biofilms formed under conditions of
flow, although the quantity of eDNA detected differed
according to growth conditions, in particular with
regards to the medium used to grow the biofilms.
Experiments with C. albicans biofilms formed stati-
cally using a microtiter plate model indicated that the
addition of exogenous DNA ([160 ng/ml) increases
biofilm biomass and, conversely, DNase treatment
([0.03 mg/ml) decreases biofilm biomass at later time
points of biofilm development. We present evidence
for the role of eDNA in C. albicans biofilm structure
and formation, consistent with eDNA being a key
element of the ECM in mature C. albicans biofilms
and playing a predominant role in biofilm structural
integrity and maintenance.
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Introduction
Biofilms are structurally complex microconsortia of
surface adhering cells embedded within an extracel-
lular matrix (ECM) composed of substances pro-
duced and secreted by cells or derived from cell lysis
[1]. The ECM contributes to the architectural pres-
ervation of biofilms by the maintenance of stable
cell–cell and cell–surface interactions and acts as a
protective barrier [2]. Although polysaccharides and
proteins are the more extensively studied substances
of biofilms ECM, other molecules such as lipids and
nucleic acids play a crucial role on ECM functions
[1]. In fact, extracellular DNA (eDNA) has been
identified in the surrounding milieu as part of the
ECM of biofilms formed by both Gram-negative
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species such as Pseudomonas aeruginosa [3] and
Gram-positive bacteria such as Bacillus cereus [4].
The proposed mechanisms implicated in eDNA
release include: (1) cell lysis, (2) quorum sensing,
and (3) excretion from DNA containing vesicles [3].
Bacterial biofilms eDNA characterization revealed
that it comprises fragments of high molecular weight
(around 30 Kb) [5] that differ from genomic DNA, as
indicated by the different profiles exhibited upon
restriction endonuclease treatments or randomly
amplified polymorphic DNA analysis [6, 7]. Evi-
dence for a role of eDNA as a structural component
of bacterial biofilms ECM arose from studies show-
ing that eDNA is required at the initial stages of
biofilm formation [8, 9]. Additionally, independent
studies evaluating exogenous DNA and DNase effect
on biofilm cells antimicrobial susceptibility [5, 10]
showed an association between eDNA and biofilms
increased antibiotic resistance.
Despite the intensive research in the bacterial field,
the investigation focusing on eDNA in fungal biofilms
is scarce.
Candida albicans is a polymorphic fungus that
causes opportunistic infections in humans and its
ability to form biofilms is well characterized [11].
C. albicans ECM abundance was recently shown to be
regulated positively by the glucoamylases Gca1 and
Gca2 and the alcohol dehydrogenase Adh5 and
negatively by the alcohol dehydrogenases Csh1
and Ifd6 [12]. C. albicans ECM consists predomi-
nantly of carbohydrates but also includes proteins,
hexosamine, uronic acid, and phosphorous [13].
Consistent with the presence of phosphorous, circum-
stantial evidences point to the presence of eDNA in
ECM. Specifically, mature biofilms treatment with
50 lg/ml of DNase resulted in 30% decrease of
biofilm biomass, similarly to the observed for pro-
teinase K treatments [13]. More recently, eDNA was
extracted from C. albicans 72 h biofilm ECM within
micrograms per gram of biofilm wet weight [14].
Additionally, it has been demonstrated that the
presence of eDNA is a common feature of biofilms
formed by other Candida species [14].
However, further studies are required to extend the
knowledge on the contribution of eDNA to C. albicans
biofilms structure and matrix composition. Here, we
examined the presence of DNA in C. albicans biofilm
ECM and the effect of DNase and the addition of
exogenous C. albicans DNA on biofilm formation.
Materials and Methods
Strain and Culture Conditions
The C. albicans wild-type strain SC5314 was used in
this study. Cells were stored at -70C in 20%
glycerol stocks and propagated by streaking a loop
full of cells onto Sabouraud dextrose agar medium
(BD, Franklin Lakes, NJ, USA) supplemented with
100 mg/l ampicillin (Fisher Bioreagents, Fair Lawn,
NJ, USA) and incubating at 30C for 24 h. These
stocks were stored at 4C for no longer than 2 weeks.
For all experiments, batches (30 ml in 125 ml flasks)
of yeast extract-peptone-dextrose (YPD) medium
[1% (w/v) yeast extract, 2% (w/v) peptone, 2% (w/v)
glucose] (US Biological, Swampscott, MA, USA)
were inoculated with freshly grown yeast cells in an
orbital shaker at 30C for 24 h. Cells were harvested
by centrifugation and washed in sterile saline. Cells
were counted with a haemocytometer and dilutions
were made to prepare standardized cell suspensions
(1 9 106 cells/ml) in the appropriate prewarmed
growth medium (see the next paragraph). Confirma-
tion of the number and viability of cells was
determined by plating serial dilutions on Sabouraud
dextrose agar. Colony-forming units were counted
after 24-h incubation at 30C.
eDNA Estimation in C. albicans Biofilm ECM
Biofilm Formation Under Conditions of Flow
Three different influent media were used (1) RPMI-
1640 supplemented with L-glutamine (Mediatech
Inc., Herdon, VA, USA), sodium bicarbonate [0.2%
(w/v)] and buffered with 0.165 M MOPS (Research
Products International Corp., Mount Prospect, IL,
USA), final pH 7, (2) YPD, and (3) yeast nitrogen
base (YNB) (Fluka, St. Louis, MO, USA) supple-
mented with glucose [0.9% (w/v)] at final pH 7. The
culture media used in the flow system were diluted in
order to promote biofilm formation. Specifically, the
chemically defined media RPMI and YNB were
diluted 1:1, whereas the rich medium YPD was
diluted 1:10. The media were supplemented with
ampicillin 100 mg/l. Culturing conditions and appa-
ratus were established as previously described [15].
Briefly, silicone elastomer (SE) strips (1 cm 9 9 cm)
(Cardiovascular Instrument Corp. Silicone sheets,
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Wakefield, MA, USA) were washed twice with
ultrapure water, sterilized by autoclaving and pre-
treated overnight at 30C with foetal calf serum
(Sigma, St. Louis, MO, USA). C. albicans standard-
ized cell suspensions (13 ml) were prepared using the
same growth medium as the influent (1 9 concen-
trated) and incubated with the SE at 37C, 130 rpm
for 90 min. After the adhesion period, the SE were
transferred to the flow system and influent medium
was set up at an initial flow rate of 0.75 ml/min [15].
Biofilms were formed at 37C for 48 h. For
subsequent analysis, two SE with biofilm were pooled
together. Two independent experiments were per-
formed for each growth medium condition.
Planktonic cultures (50 ml of standardized cell
suspension per 125 ml flask; 1 9 concentrated YPD,
RPMI, or YNB) were grown at 37C and 130 rpm for
48 h to validate the isolation of biofilm ECM (see the
next paragraph).
Isolation of Biofilm ECM
ECM was isolated as previously described [16] with
slight modifications. Briefly, after formation, the
biofilms were transferred to polypropylene conical
tubes (BD), resuspended in 10 ml of ultrapure sterile
water and vortexed for 1 min. Next, biofilm cells
were sonicated in an ultrasonic bath for 45 min,
followed by a vortexing step of 2 min and centrifuged
(2,000 rpm; 20 min). The supernatant fraction was
recovered and filtered through 0.2-lm acrodisc
syringe filters with Supor Membrane (Pall Life
Sciences, Ann Arbor, MI, USA) that are low protein
and nucleic acids binding membranes. Planktonic
cultures were processed in parallel with biofilms
during ECM extraction and aliquots were taken
before and after the sonication step. The confirmation
of planktonic cultures viability was performed by
CFU counts in Sabouraud dextrose agar medium.
ECM Analyses
The DNA of the ECM fraction was extracted with an
equal volume of phenol:chloroform:isoamyl alcohol
(25:24:1, v/v) (Invitrogen, Carlsbad, CA, USA) and
then precipitated with isopropanol (1:1, v/v). After
centrifugation, the pellet was rinsed with 70% ethanol
and air dried. The pellet was dissolved in 20 ll of TE
buffer [10 mM Tris–HCl (pH 7.5), 1 mM EDTA].
DNA was quantified using the Quant-iTTM ds BR
Assay kit (Molecular Probes, Invitrogen) according to
the suppliers’ instructions. This assay allows an
accurate determination of DNA between 100 and
1,000 ng/ml. A k DNA standard 45.7 lg/ml was
prepared in TE buffer from a commercially available
standard solution (Promega, Madison, WI, USA) and
run in parallel with samples in each assay. Addition-
ally, a blank (TE only) was also included in each
assay. Samples were read in the QuibitTM fluorometer
(Molecular Probes, Invitrogen) and a new calibration
was run for each assay. A minimum of one DNA
measurement was performed for biofilm samples.
The protein content of the ECM fraction was
estimated using the EZQ Protein Quantification kit
(Molecular Probes, Invitrogen). Standards for the
assay were prepared in nanopure water (Biorad,
Hercules, CA, USA) with ovalbumin supplied with
the kit. Standard concentrations range was between 0
and 0.25 mg/ml in order to include sample concen-
trations. Fotodyne UV 300 transilluminator (Fisher)
was used for UV measurements. Standard curves
were generated for mean UV intensity vs. ovalbumin
concentration. All measurements were made with
three replicates.
Effect of DNase and Exogenous DNA
Treatment on C. albicans Biofilm Formation
DNase I from bovine pancreas (Sigma) stock solu-
tions were prepared before each experiment in
0.15 M NaCl supplemented with 5 mM of MgCl2
(Merck, VWR, West Chester, PA, USA). The range
of concentrations chosen was based on previously
described titration data for bacterial species [17].
Working solutions of DNase in twofold increments
ranging from 0.02 to 2 mg/ml were prepared in RPMI
medium.
C. albicans genomic DNA, to be added as
exogenous DNA for C. albicans cells treatment,
was extracted with the MasterPureTM Yeast DNA
Purification kit (Epicentre Biotechnologies, Madison,
WI, USA) according to the suppliers’ instructions.
C. albicans DNA purity and concentration were
estimated by measuring the A260 and A280 (Eppendorf
Biophotometer, Eppendorf, USA). It has been previ-
ously described that in C. albicans stationary phase
planktonic cultures eDNA levels are higher than
0.1 ng/ml [18]. In this sense, physiological and
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supraphysiological concentrations ranging from 10 to
2,560 to ng/ml, with twofold increments, were chosen
for this assay. Dilutions of the genomic DNA stock
solution were prepared in RPMI medium.
For control experiments, DNase was heat inacti-
vated at 95C for 10 min and RNase (Sigma) stock
solutions were prepared in TE buffer.
DNase Treatment and Exogenous DNA Addition
at Different Stages of Biofilm Formation
Standardized cell suspensions (100 ll) were inocu-
lated into polystyrene, flat-bottomed 96-well micro-
titre plates (Corning Inc., Corning, NY, USA) and
incubated for 0, 1, 2, and 24 h at 37C under static
conditions. At 0-h (preincubation), DNase was added
to the standardized suspension. At 1-, 2-, and 24-h of
incubation the medium was removed and adhered
cells washed two times with sterile PBS (10 mM
phosphate buffer, 2.7 mM potassium chloride,
137 mM sodium chloride, pH 7.4) (Sigma). DNase
working solutions were then added to C. albicans
cells. The plates were incubated at 37C for addi-
tional 24 h. The same procedure was performed for
the addition of exogenous DNA to C. albicans cells.
Positive controls for biofilm formation included
RPMI only and RPMI plus 5 mM of MgCl2 for
DNase experiments. Negative background control for
subsequent analysis consisted of RPMI medium only.
Four independent assays with three to eight replicates
for each condition were performed. The effect of
DNase and exogenous DNA treatments was exam-
ined in terms of biofilm biomass changes using the
crystal violet assay (see next paragraph).
As controls for DNase enzymatic activity, RNase,
and heat inactivated DNase were added at 24 h as
described previously. This experiment was performed
once with eight replicates.
The effect of DNase and/or exogenous DNA on
C. albicans viability and filamentation was examined
in planktonic cultures and on preformed biofilms. For
planktonic cultures, 5 ml of the standardized cell
suspension plus (1) 5 mM of MgCl2, (2) 2 mg/ml
DNase, and (3) 2,560 ng/ml of exogenous DNA were
incubated at 37C, 130 rpm for 2 h. Viability was
examined by CFU counts in Sabouraud dextrose agar
medium. Filamentation was monitored by light
microscopy using an inverted microscope (Westover
Scientific, Mill Creek, WA, USA). These experiments
were performed twice. The highest concentrations of
DNase and exogenous DNA used in these experi-
ments did not have an effect on C. albicans planktonic
cells viability and filamentation.
For preformed biofilms, DNase ranging from 0.02
to 0.2 mg/ml was added to 24-h mature biofilms as
described previously and incubated for an additional
24 h. Next, cells were removed with a micropipette
tip, re-suspended in saline solution, and CFU analysis
was carried out. Light microscopy examination of
biofilms was performed in parallel. All the treatments
were compared with the untreated (RPMI and RPMI
plus 5 mM MgCl2) controls.
Examination of the Effect of DNase Treatment
and Exogenous DNA on Biofilm Formation
The effect of DNase and exogenous DNA on
C. albicans biofilm biomass was estimated using
the crystal violet assay. Briefly, the medium was
removed and biofilms washed twice with PBS. Then,
biofilms were stained with 50 ll of crystal violet 3 g/l
[0.3% (w/v) crystal violet (Sigma), 5% (v/v) isopro-
panol, 5% (v/v) methanol, 90% (v/v) water] for
5 min. Afterwards, each well was washed twice with
PBS, air dried, and destained with 100 ll of ethanol
100%. Next, 75 ll of the destaining solution was
transferred to a new microtiter plate, and the A550
was measured (Benchmark Microplate Reader, Bio-
Rad, Hercules, CA, USA). Samples exhibiting very
intense colour, yielding ‘‘offscale’’ absorbance val-
ues, were diluted before performing a second absor-
bance reading.
Statistical Analyses
The association between the C. albicans 48-h biofilm
ECM eDNA/protein content in the different experi-
mental conditions was analysed using the chi-square
test [19]. A statistical confidence interval of 95% was
established. The comparison between (1) log CFU/ml
before and after sonication and (2) each biofilm
treatment and control condition was performed by
two-tailed unpaired t-test (confidence interval 95%)
using GraphPad Prism, version 5.00 software for
Windows (GraphPad Software, San Diego, CA,
USA). Differences were considered significant at
P \ 0.05.
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Results
Presence of eDNA on C. albicans Biofilm ECM
Three different media were tested for their ability to
promote the accumulation of eDNA in the ECM of 48-h
C. albicans biofilms developed under flow conditions.
In the extraction of ECM, it was mandatory to
ensure that there was no leak of cellular DNA during
sample processing. To validate the ECM extraction
process 48-h planktonic cultures were handled in
parallel with biofilm samples. Before and after
samples processing, aliquots were collected and
CFU analysis was carried out. Difference between
mean log CFU/ml before and after sonication was of:
0.00 (P = 1.00) for RPMI, -0.07 (P = 0.39) for
YPD, and 0.00 (P = 1.00) for YNB.
As shown in Table 1, irrespective of which medium
was used, eDNA was detected at measurable levels in
ECM of C. albicans biofilms. Under the conditions
used in this assay, the highest levels of eDNA in ECM
were observed for biofilms formed using RPMI
medium (3,045.4 ± 227.3 ng eDNA/mg of protein).
These levels were 9-fold higher than those observed in
the ECM of biofilms grown in YPD (Table 1;
P \ 0.01, Table 2). Both the absolute quantities of
eDNA and the ratio of eDNA/protein were lowest in
the ECM from YNB-grown biofilms when compared
to biofilms grown in RPMI and YPD (Tables 1, 2).
This data shows that eDNA is a component of
C. albicans biofilm matrix and suggests that its accu-
mulation in the ECM is affected by culture conditions.
Effect of DNase Treatment on C. albicans
Biofilm Formation
In order to examine the possible role of eDNA on
C. albicans biofilm development, in the first set of
experiments DNase was added to cells at different
times (0, 1, 2, and 24 h) in the wells of microtiter
plates and biofilms formation allowed to proceed for
an additional 24 h (Fig. 1). The results of these
experiments, assessed by a colorimetric assay for
biofilm biomass showed that DNase did not exhibit
major effects on C. albicans adherent cells at early
time points during biofilm development (Fig. 1).
DNase was also used to treat preformed biofilms
(24 h) to determine whether different concentrations
of this enzyme could affect the formed biofilms. As
shown in Fig. 1, DNase showed a general inhibitory
effect on C. albicans preformed biofilms. This was
reflected by lower crystal violet readings at DNase
concentrations higher than 0.03 mg/ml. For example,
biofilms treated for 24 h with 0.13 mg/ml DNase
showed a reduction of 40% in A550 readings when
compared with the control (P = 0.03). Furthermore,
preformed biofilms treatment with RNase and heat
inactivated DNase at the same concentrations used
for DNase did not display a decrease in biofilm
biomass (data not shown), demonstrating that DNase
activity is required for the observed effect.
Additionally, it should be noted that microscopic
examination of biofilms, before washing, in terms of
density and filamentation suggested that the DNase-
treated biofilms (Fig. 2I-b) resembled the control
biofilms (Fig. 2I-a). However, during the biofilm
processing for the determination of biofilm biomass,
Table 1 C. albicans 48-h biofilm ECM eDNA and protein content
Influent medium eDNAa (ng) Proteina (mg) eDNA/protein (ng/mg)
RPMIb 1,518 ± 822 0.48 ± 0.2 3,045.4 ± 227.3
YPDc 180 ± 160 0.42 ± 0.1 339.6 ± 265.6
YNBb 1.8 ± 1.6 0.10 ± 0.1 13.0 ± 8.8
DNA was extracted and further quantified. Protein content was directly assayed from the samples. Data presented represents
mean ± mean deviation
a Obtained from biofilms developed under flow conditions, corresponding to 18 cm2 of area; bused at 1:1 dilution; cused at 1:10
dilution
Table 2 Results of the statistical analysis of C. albicans 48-h
biofilm ECM ng eDNA/mg of protein content (P values)
obtained in the different experimental conditions
Media P value
RPMI vs. YPD \ 0.01
YPD vs. YNB \ 0.01
YNB vs. RPMI \ 0.01
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the DNase-treated biofilms did detach from the
microtiter plate surface (Fig. 2II-d), resulting in
decreased A550, in contrast to non-treated biofilms
(Fig. 2II-c). Accordingly, the assessment of cell
viability of prewashed biofilms did not reveal a
detrimental effect of DNase on biofilm cells viability
(compared with the control). For example, for 24-h
treatment with 0.13 mg/ml DNase, the log CFU/well
was 6.1 vs. 6.5 for control biofilms.
This suggests that the observed effect induced by
DNase treatment is not due to changes in biofilm cells
growth or filamentation, but rather due to a direct
effect on the biofilm ECM which is important for
biofilm integrity and maintenance.
Effect of Addition Exogenous DNA on
C. albicans Biofilm Formation
To further substantiate the effect of eDNA as a
structural component of biofilms, exogenous DNA
was added to C. albicans cells. As shown in Fig. 3,
the addition of exogenous DNA to C. albicans
adhered cell populations did not affect further biofilm
development. In contrast, addition of exogenous
DNA, at concentrations higher than 160 ng/ml to
Fig. 1 Effect of DNase treatment on C. albicans biofilm
formation. Different DNase concentrations (0, 0.02, 0.03, 0.06,
0.13, 0.25, 0.50, 1.00, and 2.00 mg/ml) were added to
C. albicans cells at different times (0, 1, 2, and 24 h) of
incubation in the wells of microtiter plates and incubated at
37C under static conditions. The extent of biofilm formation
was estimated by the crystal violet assay. Presented values are
mean A550 ± standard error of mean of four independent
experiments with three to eight replicates. Statistically
significant differences (compared to biofilms formed in the
absence of DNase) are indicated with an asterisk. (*P \ 0.05)
Fig. 2 Example of microscopy evaluation of the effect of
DNase treatment on 24-h C. albicans biofilm formation.
Microphotographs of cells in wells before (I) and after (II)
aspiration of medium and subsequent washings with PBS for
biofilms treated with 0 mg/ml (a and c) and 0.13 mg/ml of
DNase (b and d). The bar in the picture represents 200 lm
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mature biofilms led to increases in biofilm biomass,
as indicated by the differences in A550 readings
compared with control biofilms (grown in the absence
of exogenous DNA) (Fig. 3). As an example, under
the exposure to 320 ng/ml of exogenous DNA,
biofilm biomass increased up to 63% in comparison
with untreated biofilms (P = 0.03).
These experiments indicate that eDNA may con-
tribute to the maintenance and stability of C. albicans
mature biofilms, but is not required for the early
stages of biofilms establishment.
Discussion
In recent years, there has been an increasing interest
in the natural sources and target effects of the nucleic
acids found outside the cells in several biological
systems [20]. However, the study of eDNA in
C. albicans biofilms has not been the subject of
extensive research. Here, a series of experiments
were designed to specifically address the contribution
of eDNA to C. albicans biofilms ECM.
For this, we first determined the eDNA content
from the ECM of 48-h biofilms using three different
culture media, to ensure that eDNA is a component
of ECM under different environmental growth
conditions. Biofilms were developed in a flow model
due to the predicted higher amounts of exopolymeric
material that could be obtained when compared to
biofilms developed under static conditions [15, 21].
Regardless of the growth medium used, eDNA was
found to be a component of C. albicans ECM in all
conditions used (Table 1). In this study, it was
noticed that the amount of eDNA varied considerably
with the growth medium used, with RPMI favouring
the accumulation of eDNA in the ECM of C. albicans
biofilms (Tables 1, 2). As the DNA content in the
effluent medium was not determined, it cannot be
discarded that biofilm cells grown in YPD released
more eDNA compared with RPMI but the ECM
amount/composition of RPMI biofilms promotes the
accumulation of DNA. It should be noted that the
association between ECM eDNA/protein content and
growth medium was observed for biofilms formed in
flow model.
The release of eDNA into the extracellular
medium is not biofilm cells specific. It has been
previously reported the release of DNA into the
supernatant of C. albicans planktonic cells grown in
RPMI and Hank’s balanced salt solution [18]. The
highest levels of eDNA attained in the stationary
phase of growth have been suggested to result from
cell death due to the nutrient depletion and toxic
Fig. 3 Effect of addition of exogenous DNA on C. albicans
biofilm formation. Different exogenous DNA concentrations
(0, 20, 40, 80, 160, 320, 640, 1,280, and 2,560 ng/ml) were
added to C. albicans cells at different times (0, 1, 2, and 24 h)
of incubation in the wells of microtiter plates and incubated at
37C under static conditions. The extent of biofilm formation
was estimated by the crystal violet assay. Presented values are
mean A550 ± standard error of mean of four independent
experiments with three to eight replicates. Statistically
significant differences (compared to biofilms formed in the
absence of exogenous DNA) are indicated with an asterisk.
(*P \ 0.05)
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metabolites accumulation [18]. We also determined
the amount of free DNA in the supernatant of 48-h
grown C. albicans planktonic cultures and observed
the following hierarchy of eDNA accumulation rela-
tive to the amount of protein: YPD [ RPMI [ YNB
(unpublished data).
In bacteria, it was proposed that quorum sensing is
one of the mechanisms that contributes to increased
release of eDNA into the environment [22]. Recently,
the eDNA content of C. albicans chk1/chk1 biofilm
ECM was determined [14], which is a mutant strain
known to be non-responsive to the C. albicans
quorum sensing molecule farnesol [23]. The ECM
of the mutant strain contained only slightly lower
eDNA and protein levels/biofilm wet weight in
comparison with the wild-type strain [14], suggesting
that DNA release by C. albicans biofilm cells may
not be a controlled step linked to cell–cell commu-
nication through farnesol.
Regardless the factors that promote eDNA accu-
mulation, it was important to address the role of this
ECM component in C. albicans biofilms. Circum-
stantial evidences have shown that DNA may play a
structural role in C. albicans 48-h biofilms [13]. In
this sense, we evaluated the impact of eDNA removal
by DNase (Fig. 1), and addition of exogenous DNA
(Fig. 3) at different stages of C. albicans biofilm
formation. For the determination of the effect of these
treatments on biofilms, a rapid and robust method,
such as the 96-well plate model [24] that allows
testing of multiple parameters in the same experiment
was preferred. Furthermore, RPMI medium was the
choice medium for the following experiments
because it provides an optimal pH for DNase activity.
Results from these series of experiments demonstrate
that eDNA is an important component of C. albicans
mature biofilms contributing to its maintenance and
stability but is not required for the establishment of
biofilms or during the very early phases of biofilm
development (Figs. 1, 3).
Although it has not been determined how biofilms
grown in 96-well plates compared to those developed
under flow conditions the conjugation of the data
obtained from the two models is consistent with
eDNA being a key element of the ECM in mature
C. albicans biofilms and playing a predominant role in
biofilm structural integrity and maintenance. How-
ever, we note that eDNA role in Candida biofilms
may be species/strain dependent since a previous
study reported that C. tropicalis biofilm biomass is not
affected by 50 lg/ml DNase treatment [13]. Data
presented in this work also points to a differential role
of eDNA among C. albicans and bacterial biofilms. In
fact, for several bacterial species eDNA is required for
the initial attachment as well as for subsequent early
phases of biofilm formation, but only for some species
DNA was found to be an important structural
component of mature biofilms [8, 9].
In the last years, several lines of evidence
suggested that in vivo eDNA has a functional activity
in the regulation of host immune response. On one
hand, it was demonstrated that the administration of
C. albicans DNA to mice at specific time points prior
to infection promoted mice survival [25, 26]. On the
other hand, it was demonstrated that after C. albicans
infection of non-neutropenic rabbits fungal eDNA
was detected in the plasma within the first 24 h and
increased over the course of disease [18]. This eDNA
may be available for interaction with Toll-like
receptor 9 (TLR9), an intracellular fungal DNA
receptor, as evidenced by studies showing C. albicans
eDNA activation of bone marrow-derived myeloid
dendritic cells through the TLR9/Myeloid differenti-
ation factor 88 signalling pathway [27], and the
increased survival of TLR9 deficient mice upon
challenge with C. albicans hyphae [28]. We can
hypothesize that eDNA present on C. albicans
biofilms may contribute to the modulation of host
immune response.
Overall, this work reveals novel aspects of the role
of eDNA on C. albicans biofilms, and properties of
biofilm ECM that contribute to a better understanding
of C. albicans biofilm lifestyle.
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